| |
MIC (µg/mL) |
| EFSA Breakpoint Bifidobacteriuma |
B. longum CECT 7347 |
| Amoxicillin |
n.r. |
8 |
| Ampicillin |
2 |
2 |
| Carbenicillin |
n.r. |
32 |
| Clarithromycin |
n.r. |
128 |
| Clindamycin |
0.25 |
0.25 |
| Chloramphenicol |
4 |
1 |
| Erythromycin |
0.5 |
1 |
| Streptomycin |
128 |
64 |
| Gentamicin |
64 |
32 |
| Kanamycin |
n.r. |
8 |
| Metronidazole |
n.r. |
128 |
| Nalidixic acid |
n.r. |
>256 |
| Oxytetracycline |
n.r. |
4 |
| Penicillin |
n.r. |
1 |
| Polymyxin B |
n.r. |
>256 |
| Rifampin |
n.r. |
>256 |
| Sulfonamide |
n.r. |
>256 |
| Tetracycline |
8 |
8 |
| Trimethoprim |
n.r. |
>256 |
| Vancomycin |
2 |
0.5 |
|
| aEuropean Food Safety Authority [22]; n.r.: not recommended |
| Table 1: Sensitivities to antibiotics of the isolated strain CECT 7347 compared with commercial strain B. longum BB536. Data are expressed as means (n=3). |
